>Remdesivir has a minor beneficial impact when delivered VERY EARLY.
There's still a couple of problems though:
* It has to be delivered by IV drip
* It's in short supply
* It's expensive
Which means that realistically, the only way to get a positive impact from it would be to send high-risk patients who were very likely to have just been exposed to the hospital for the injection. Even then, the risk-value proposition does not seem that great.